- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07015632
- Original Trial
ML-Based Multi-Sensor Fall Risk Screening in DMD
Quantitative Analysis of Upper Extremity Functional Movement of the Upper Extremity in Patients With Duchenne Muscular Dystrophy
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: JungHyun Kim, prof
- Phone Number: 82+1088632341
- Email: kiking0@naver.com
Study Locations
-
-
Jongno
-
Seoul, Jongno, Korea, Republic of, 03080
- Recruiting
- Seoul National University Hospital
-
Contact:
- junghyun kim, Ph. D.
- Phone Number: 82+1021740890
- Email: kiking0@naver.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Individuals with a confirmed genetic diagnosis of Duchenne Muscular Dystrophy (DMD)
- Age over 10 and under 30 years
- Brooke Scale score between 2 and 5
- Manual muscle test grade below 3 for shoulder abduction muscles
Exclusion Criteria:
- Individuals who are unable or unwilling to provide informed consent
- Brooke Scale score of 1 or 6
- Individuals with cognitive impairments that significantly limit their ability to participate in assessments
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Performance of the upper limb module 2.0
Time Frame: baseline - 6 months - 12 months
|
The Performance of the Upper Limb (PUL) Module 2.0 is a validated assessment tool designed to evaluate upper limb function in individuals with Duchenne Muscular Dystrophy.
The PUL 2.0 consists of 22 items covering three domains: shoulder level, mid-level (elbow), and distal level (hand).
Each item is scored based on task performance, and the total score ranges from 0 to 42, with higher scores indicating better upper limb function.
|
baseline - 6 months - 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brooke score
Time Frame: baseline - 6 months - 12 months
|
The Brooke Upper Extremity Functional Rating Scale is a 6-point scale used to evaluate upper limb functional ability, primarily in patients with neuromuscular disorders such as Duchenne Muscular Dystrophy. Scores range from 1 to 6, where: 1 = Able to abduct arms in a full circle until they touch above the head 6 = Cannot raise hands to the mouth and has no useful function of the hands Lower scores indicate better upper limb function. |
baseline - 6 months - 12 months
|
|
grip strength
Time Frame: baseline - 6 months - 12 months
|
Grip strength will be measured using the Jamar Plus+ Digital Hand Dynamometer, a validated and widely used device for quantifying hand grip strength in kilograms (kg).
Participants will be instructed to sit upright with the shoulder adducted and neutrally rotated, elbow flexed at 90 degrees, forearm in neutral position, and wrist in 0 to 30 degrees extension.
The average of three consecutive trials will be recorded for each assessment.
Higher values indicate greater grip strength.
|
baseline - 6 months - 12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0420232060
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.